Can Fite Biofarma Ltd (CANF)

1.48 +0.04 (+2.78%) USD  |  NYAM  |  Dec 20, 16:00
1.48 0.00 (0.00%) Pre-Market: 20:00
More

Can Fite Biofarma Debt to Equity Ratio: 0.00 for Dec. 31, 2023

Debt to Equity Ratio Chart

View Debt to Equity Ratio for CANF.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Debt to Equity Ratio Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Debt to Equity Ratio Definition

View Debt to Equity Ratio Definition
Start Trial

The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.

Read full definition.

Debt to Equity Ratio Range, Past 5 Years

View Debt to Equity Ratio Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Debt to Equity Ratio Benchmarks

View Debt to Equity Ratio Benchmarks
Start Trial
Compugen Ltd 0.00
Pluri Inc -4.801
BioLine Rx Ltd 3.269
XTL Biopharmaceuticals Ltd --
BiomX Inc --

Debt to Equity Ratio Related Metrics

Total Assets (Quarterly) 9.989M
Total Liabilities (Quarterly) 3.746M
Shareholders Equity (Quarterly) 6.243M
Current Ratio 4.905